2021-2027 Global and Regional Equine Pharmaceuticals and Supplements Industry Status and Prospects Professional Market Research Report Standard Version
Date: Aug-2021 | Id: MACRC-72128 | Geographical Scope: Global | Publisher: Mnemonics Research
The global Equine Pharmaceuticals and Supplements market was valued at 99.96 Million USD in 2020 and will grow with a CAGR of 4.25% from 2020 to 2027, based on Mnemonics Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America). Equine Pharmaceuticals and Supplements are medicines or supplements that are specially used to supplement nutrition and cure diseases.In the last several years, global market of Equine Pharmaceuticals and Supplements developed rapidly, with an average growth rate of 4.52% during 2013 to 2017. In 2017, global revenue of Equine Pharmaceuticals and Supplements is nearly 977 M USD; the actual production is about 13700 K Unit. Market competition is not intense. Boehringer Ingelheim, Merck Animal Health, Zoetis, Bayer Animal Health, Elanco Animal Health, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers. By Market Verdors: Boehringer Ingelheim Merck Animal Health Zoetis Bayer Animal Health Elanco Animal Health Dechra Veterinary Products CEVA Virbac Norbrook Equine Kyoritsu Seiyaku Vetoquinol Protexin Healthcare Audevard Ouro Fino Saude By Types: Pharmaceuticals Supplements By Applications: Thoroughbred Horse Key Indicators Analysed Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors. Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications. Market Trends: Market key trends which include Increased Competition and Continuous Innovations. Opportunities and <b>Drivers:</b> Identifying the Growing Demands and New Technology Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry. Key Reasons to Purchase To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape. Assess the production processes, major issues, and solutions to mitigate the development risk. To understand the most affecting driving and restraining forces in the market and its impact in the global market. Learn about the market strategies that are being adopted by leading respective organizations. To understand the future outlook and prospects for the market. Besides the standard structure reports, we also provide custom research according to specific requirements.
Chapter 1 Industry Overview 1.1 Definition 1.2 Assumptions 1.3 Research Scope 1.4 Market Analysis by Regions 1.4.1 North America Market States and Outlook (2022-2027) 1.4.2 East Asia Market States and Outlook (2022-2027) 1.4.3 Europe Market States and Outlook (2022-2027) 1.4.4 South Asia Market States and Outlook (2022-2027) 1.4.5 Southeast Asia Market States and Outlook (2022-2027) 1.4.6 Middle East Market States and Outlook (2022-2027) 1.4.7 Africa Market States and Outlook (2022-2027) 1.4.8 Oceania Market States and Outlook (2022-2027) 1.4.9 South America Market States and Outlook (2022-2027) 1.5 Global Equine Pharmaceuticals and Supplements Market Size Analysis from 2022 to 2027 1.5.1 Global Equine Pharmaceuticals and Supplements Market Size Analysis from 2022 to 2027 by Consumption Volume 1.5.2 Global Equine Pharmaceuticals and Supplements Market Size Analysis from 2022 to 2027 by Value 1.5.3 Global Equine Pharmaceuticals and Supplements Price Trends Analysis from 2022 to 2027 1.6 COVID-19 Outbreak: Equine Pharmaceuticals and Supplements Industry Impact Chapter 2 Global Equine Pharmaceuticals and Supplements Competition by Types, Applications, and Top Regions and Countries 2.1 Global Equine Pharmaceuticals and Supplements (Volume and Value) by Type 2.1.1 Global Equine Pharmaceuticals and Supplements Consumption and Market Share by Type (2016-2021) 2.1.2 Global Equine Pharmaceuticals and Supplements Revenue and Market Share by Type (2016-2021) 2.2 Global Equine Pharmaceuticals and Supplements (Volume and Value) by Application 2.2.1 Global Equine Pharmaceuticals and Supplements Consumption and Market Share by Application (2016-2021) 2.2.2 Global Equine Pharmaceuticals and Supplements Revenue and Market Share by Application (2016-2021) 2.3 Global Equine Pharmaceuticals and Supplements (Volume and Value) by Regions 2.3.1 Global Equine Pharmaceuticals and Supplements Consumption and Market Share by Regions (2016-2021) 2.3.2 Global Equine Pharmaceuticals and Supplements Revenue and Market Share by Regions (2016-2021) Chapter 3 Production Market Analysis 3.1 Global Production Market Analysis 3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis 3.1.2 2016-2021 Major Manufacturers Performance and Market Share 3.2 Regional Production Market Analysis 3.2.1 2016-2021 Regional Market Performance and Market Share 3.2.2 North America Market 3.2.3 East Asia Market 3.2.4 Europe Market 3.2.5 South Asia Market 3.2.6 Southeast Asia Market 3.2.7 Middle East Market 3.2.8 Africa Market 3.2.9 Oceania Market 3.2.10 South America Market 3.2.11 Rest of the World Market Chapter 4 Global Equine Pharmaceuticals and Supplements Sales, Consumption, Export, Import by Regions (2016-2021) 4.1 Global Equine Pharmaceuticals and Supplements Consumption by Regions (2016-2021) 4.2 North America Equine Pharmaceuticals and Supplements Sales, Consumption, Export, Import (2016-2021) 4.3 East Asia Equine Pharmaceuticals and Supplements Sales, Consumption, Export, Import (2016-2021) 4.4 Europe Equine Pharmaceuticals and Supplements Sales, Consumption, Export, Import (2016-2021) 4.5 South Asia Equine Pharmaceuticals and Supplements Sales, Consumption, Export, Import (2016-2021) 4.6 Southeast Asia Equine Pharmaceuticals and Supplements Sales, Consumption, Export, Import (2016-2021) 4.7 Middle East Equine Pharmaceuticals and Supplements Sales, Consumption, Export, Import (2016-2021) 4.8 Africa Equine Pharmaceuticals and Supplements Sales, Consumption, Export, Import (2016-2021) 4.9 Oceania Equine Pharmaceuticals and Supplements Sales, Consumption, Export, Import (2016-2021) 4.10 South America Equine Pharmaceuticals and Supplements Sales, Consumption, Export, Import (2016-2021) Chapter 5 North America Equine Pharmaceuticals and Supplements Market Analysis 5.1 North America Equine Pharmaceuticals and Supplements Consumption and Value Analysis 5.1.1 North America Equine Pharmaceuticals and Supplements Market Under COVID-19 5.2 North America Equine Pharmaceuticals and Supplements Consumption Volume by Types 5.3 North America Equine Pharmaceuticals and Supplements Consumption Structure by Application 5.4 North America Equine Pharmaceuticals and Supplements Consumption by Top Countries 5.4.1 United States Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021 5.4.2 Canada Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021 5.4.3 Mexico Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021 Chapter 6 East Asia Equine Pharmaceuticals and Supplements Market Analysis 6.1 East Asia Equine Pharmaceuticals and Supplements Consumption and Value Analysis 6.1.1 East Asia Equine Pharmaceuticals and Supplements Market Under COVID-19 6.2 East Asia Equine Pharmaceuticals and Supplements Consumption Volume by Types 6.3 East Asia Equine Pharmaceuticals and Supplements Consumption Structure by Application 6.4 East Asia Equine Pharmaceuticals and Supplements Consumption by Top Countries 6.4.1 China Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021 6.4.2 Japan Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021 6.4.3 South Korea Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021 Chapter 7 Europe Equine Pharmaceuticals and Supplements Market Analysis 7.1 Europe Equine Pharmaceuticals and Supplements Consumption and Value Analysis 7.1.1 Europe Equine Pharmaceuticals and Supplements Market Under COVID-19 7.2 Europe Equine Pharmaceuticals and Supplements Consumption Volume by Types 7.3 Europe Equine Pharmaceuticals and Supplements Consumption Structure by Application 7.4 Europe Equine Pharmaceuticals and Supplements Consumption by Top Countries 7.4.1 Germany Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021 7.4.2 UK Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021 7.4.3 France Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021 7.4.4 Italy Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021 7.4.5 Russia Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021 7.4.6 Spain Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021 7.4.7 Netherlands Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021 7.4.8 Switzerland Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021 7.4.9 Poland Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021 Chapter 8 South Asia Equine Pharmaceuticals and Supplements Market Analysis 8.1 South Asia Equine Pharmaceuticals and Supplements Consumption and Value Analysis 8.1.1 South Asia Equine Pharmaceuticals and Supplements Market Under COVID-19 8.2 South Asia Equine Pharmaceuticals and Supplements Consumption Volume by Types 8.3 South Asia Equine Pharmaceuticals and Supplements Consumption Structure by Application 8.4 South Asia Equine Pharmaceuticals and Supplements Consumption by Top Countries 8.4.1 India Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021 8.4.2 Pakistan Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021 8.4.3 Bangladesh Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021 Chapter 9 Southeast Asia Equine Pharmaceuticals and Supplements Market Analysis 9.1 Southeast Asia Equine Pharmaceuticals and Supplements Consumption and Value Analysis 9.1.1 Southeast Asia Equine Pharmaceuticals and Supplements Market Under COVID-19 9.2 Southeast Asia Equine Pharmaceuticals and Supplements Consumption Volume by Types 9.3 Southeast Asia Equine Pharmaceuticals and Supplements Consumption Structure by Application 9.4 Southeast Asia Equine Pharmaceuticals and Supplements Consumption by Top Countries 9.4.1 Indonesia Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021 9.4.2 Thailand Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021 9.4.3 Singapore Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021 9.4.4 Malaysia Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021 9.4.5 Philippines Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021 9.4.6 Vietnam Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021 9.4.7 Myanmar Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021 Chapter 10 Middle East Equine Pharmaceuticals and Supplements Market Analysis 10.1 Middle East Equine Pharmaceuticals and Supplements Consumption and Value Analysis 10.1.1 Middle East Equine Pharmaceuticals and Supplements Market Under COVID-19 10.2 Middle East Equine Pharmaceuticals and Supplements Consumption Volume by Types 10.3 Middle East Equine Pharmaceuticals and Supplements Consumption Structure by Application 10.4 Middle East Equine Pharmaceuticals and Supplements Consumption by Top Countries 10.4.1 Turkey Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021 10.4.2 Saudi Arabia Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021 10.4.3 Iran Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021 10.4.4 United Arab Emirates Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021 10.4.5 Israel Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021 10.4.6 Iraq Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021 10.4.7 Qatar Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021 10.4.8 Kuwait Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021 10.4.9 Oman Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021 Chapter 11 Africa Equine Pharmaceuticals and Supplements Market Analysis 11.1 Africa Equine Pharmaceuticals and Supplements Consumption and Value Analysis 11.1.1 Africa Equine Pharmaceuticals and Supplements Market Under COVID-19 11.2 Africa Equine Pharmaceuticals and Supplements Consumption Volume by Types 11.3 Africa Equine Pharmaceuticals and Supplements Consumption Structure by Application 11.4 Africa Equine Pharmaceuticals and Supplements Consumption by Top Countries 11.4.1 Nigeria Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021 11.4.2 South Africa Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021 11.4.3 Egypt Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021 11.4.4 Algeria Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021 11.4.5 Morocco Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021 Chapter 12 Oceania Equine Pharmaceuticals and Supplements Market Analysis 12.1 Oceania Equine Pharmaceuticals and Supplements Consumption and Value Analysis 12.2 Oceania Equine Pharmaceuticals and Supplements Consumption Volume by Types 12.3 Oceania Equine Pharmaceuticals and Supplements Consumption Structure by Application 12.4 Oceania Equine Pharmaceuticals and Supplements Consumption by Top Countries 12.4.1 Australia Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021 12.4.2 New Zealand Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021 Chapter 13 South America Equine Pharmaceuticals and Supplements Market Analysis 13.1 South America Equine Pharmaceuticals and Supplements Consumption and Value Analysis 13.1.1 South America Equine Pharmaceuticals and Supplements Market Under COVID-19 13.2 South America Equine Pharmaceuticals and Supplements Consumption Volume by Types 13.3 South America Equine Pharmaceuticals and Supplements Consumption Structure by Application 13.4 South America Equine Pharmaceuticals and Supplements Consumption Volume by Major Countries 13.4.1 Brazil Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021 13.4.2 Argentina Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021 13.4.3 Columbia Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021 13.4.4 Chile Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021 13.4.5 Venezuela Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021 13.4.6 Peru Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021 13.4.7 Puerto Rico Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021 13.4.8 Ecuador Equine Pharmaceuticals and Supplements Consumption Volume from 2016 to 2021 Chapter 14 Company Profiles and Key Figures in Equine Pharmaceuticals and Supplements Business 14.1 Boehringer Ingelheim 14.1.1 Boehringer Ingelheim Company Profile 14.1.2 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Product Specification 14.1.3 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.2 Merck Animal Health 14.2.1 Merck Animal Health Company Profile 14.2.2 Merck Animal Health Equine Pharmaceuticals and Supplements Product Specification 14.2.3 Merck Animal Health Equine Pharmaceuticals and Supplements Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.3 Zoetis 14.3.1 Zoetis Company Profile 14.3.2 Zoetis Equine Pharmaceuticals and Supplements Product Specification 14.3.3 Zoetis Equine Pharmaceuticals and Supplements Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.4 Bayer Animal Health 14.4.1 Bayer Animal Health Company Profile 14.4.2 Bayer Animal Health Equine Pharmaceuticals and Supplements Product Specification 14.4.3 Bayer Animal Health Equine Pharmaceuticals and Supplements Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.5 Elanco Animal Health 14.5.1 Elanco Animal Health Company Profile 14.5.2 Elanco Animal Health Equine Pharmaceuticals and Supplements Product Specification 14.5.3 Elanco Animal Health Equine Pharmaceuticals and Supplements Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.6 Dechra Veterinary Products 14.6.1 Dechra Veterinary Products Company Profile 14.6.2 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Product Specification 14.6.3 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.7 CEVA 14.7.1 CEVA Company Profile 14.7.2 CEVA Equine Pharmaceuticals and Supplements Product Specification 14.7.3 CEVA Equine Pharmaceuticals and Supplements Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.8 Virbac 14.8.1 Virbac Company Profile 14.8.2 Virbac Equine Pharmaceuticals and Supplements Product Specification 14.8.3 Virbac Equine Pharmaceuticals and Supplements Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.9 Norbrook Equine 14.9.1 Norbrook Equine Company Profile 14.9.2 Norbrook Equine Equine Pharmaceuticals and Supplements Product Specification 14.9.3 Norbrook Equine Equine Pharmaceuticals and Supplements Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.10 Kyoritsu Seiyaku 14.10.1 Kyoritsu Seiyaku Company Profile 14.10.2 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Product Specification 14.10.3 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.11 Vetoquinol 14.11.1 Vetoquinol Company Profile 14.11.2 Vetoquinol Equine Pharmaceuticals and Supplements Product Specification 14.11.3 Vetoquinol Equine Pharmaceuticals and Supplements Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.12 Protexin Healthcare 14.12.1 Protexin Healthcare Company Profile 14.12.2 Protexin Healthcare Equine Pharmaceuticals and Supplements Product Specification 14.12.3 Protexin Healthcare Equine Pharmaceuticals and Supplements Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.13 Audevard 14.13.1 Audevard Company Profile 14.13.2 Audevard Equine Pharmaceuticals and Supplements Product Specification 14.13.3 Audevard Equine Pharmaceuticals and Supplements Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.14 Ouro Fino Saude 14.14.1 Ouro Fino Saude Company Profile 14.14.2 Ouro Fino Saude Equine Pharmaceuticals and Supplements Product Specification 14.14.3 Ouro Fino Saude Equine Pharmaceuticals and Supplements Production Capacity, Revenue, Price and Gross Margin (2016-2021) Chapter 15 Global Equine Pharmaceuticals and Supplements Market Forecast (2022-2027) 15.1 Global Equine Pharmaceuticals and Supplements Consumption Volume, Revenue and Price Forecast (2022-2027) 15.1.1 Global Equine Pharmaceuticals and Supplements Consumption Volume and Growth Rate Forecast (2022-2027) 15.1.2 Global Equine Pharmaceuticals and Supplements Value and Growth Rate Forecast (2022-2027) 15.2 Global Equine Pharmaceuticals and Supplements Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027) 15.2.1 Global Equine Pharmaceuticals and Supplements Consumption Volume and Growth Rate Forecast by Regions (2022-2027) 15.2.2 Global Equine Pharmaceuticals and Supplements Value and Growth Rate Forecast by Regions (2022-2027) 15.2.3 North America Equine Pharmaceuticals and Supplements Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.2.4 East Asia Equine Pharmaceuticals and Supplements Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.2.5 Europe Equine Pharmaceuticals and Supplements Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.2.6 South Asia Equine Pharmaceuticals and Supplements Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.2.7 Southeast Asia Equine Pharmaceuticals and Supplements Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.2.8 Middle East Equine Pharmaceuticals and Supplements Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.2.9 Africa Equine Pharmaceuticals and Supplements Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.2.10 Oceania Equine Pharmaceuticals and Supplements Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.2.11 South America Equine Pharmaceuticals and Supplements Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.3 Global Equine Pharmaceuticals and Supplements Consumption Volume, Revenue and Price Forecast by Type (2022-2027) 15.3.1 Global Equine Pharmaceuticals and Supplements Consumption Forecast by Type (2022-2027) 15.3.2 Global Equine Pharmaceuticals and Supplements Revenue Forecast by Type (2022-2027) 15.3.3 Global Equine Pharmaceuticals and Supplements Price Forecast by Type (2022-2027) 15.4 Global Equine Pharmaceuticals and Supplements Consumption Volume Forecast by Application (2022-2027) 15.5 Equine Pharmaceuticals and Supplements Market Forecast Under COVID-19 Chapter 16 Conclusions Research Methodology
Related reports
Non-Hodgkin Lymphoma Therapeutics Market
$2000-$6000
Acrylic Teeth Market
$3600-$7000